MDP Medexus Pharmaceuticals Inc.

3.992USD5.710 CAD · TSX-4.36%Mkt Cap: 125.44M USDP/E: —

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and…

Insiders, last 90 days22 buys
Institutional holders9 on file

Key Statistics

Company
Market Cap125.44M USD
Enterprise Value136.98M USD
Revenue (TTM)107.66M USD
Gross Profit54.41M USD
Net Income (TTM)-2.39M USD
Revenue/Share3.37 USD
Last Price3.992 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees90
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58410Q2036
Valuation
P/E (Trailing)—
P/E (Forward)-285.50
PEG—
EV/EBITDA11.25
EV/Revenue1.27
P/S1.67
P/B2.62
EPS (TTM)-0.06 USD
EPS (Forward)-0.02 USD
52W Range
1.75590% of range4.229
52W High4.229 USD
52W Low1.755 USD
Profitability
Gross Margin54.78%
Oper. Margin7.32%
EBITDA Margin16.18%
Profit Margin-2.41%
ROE-4.89%
ROA-1.63%
ROIC9.01%
ROCE6.23%
Growth
Revenue Growth17.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.87M USD
CapEx (TTM)15.15M USD
FCF Margin-10.75%
FCF Yield-9.22%
Net Debt17.87M USD
Net Debt/EBITDA1.03
Net Debt/FCF—
Balance Sheet
Debt/Equity0.45
Current Ratio1.27
Quick Ratio0.43
Book Value/Sh2.18 USD
Cash/Share0.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 19, 2018
Splits
Last Split1:15
Split DateDec 19, 2018
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.341 USD
Upside (mean)+33.8%
Target Range4.544 USD – 6.291 USD
4.544+33.8% to mean6.291
# Analysts5
Ownership
Shares Out.31.43M
Float28.61M
Insiders8.02%
Institutions3.47%
Short Interest
Short Ratio3.0d
Short % Out.0.34%
Shares Short107.36K
Short (prev mo.)116.64K
Technical
SMA 503.540 (+12.8%)
SMA 2003.018 (+32.3%)
Beta1.68
S&P 52W Chg12.00%
Avg Vol (30d)42.21K
Avg Vol (10d)67.42K
Technical Indicators
RSI (14)61.4
MACD0.2276
MACD Signal0.1435
MACD Hist.+0.0841
BB Upper4.196 USD
BB Middle3.664 USD
BB Lower3.133 USD
BB Width29.00%
ATR (14)0.1505 USD
Vol Ratio (20d)0.81x

About Medexus Pharmaceuticals (TSE: MDP)

›

Medexus Pharmaceuticals (TSE: MDP) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 90 employees.

The shares were at 5.710 CAD on 19 November 2026, up 111.5% over 52 weeks. Its 52-week range is 2.510 CAD to 6.050 CAD: the price is 5.6% below the high and 127.5% above the low.

Its market capitalisation is 179.44M CAD.

Medexus Pharmaceuticals reports return on equity of -4.9%, an operating margin of 7.3% and revenue up 17.6% year over year.

Its debt exceeds its cash by 17.87M USD, a debt-to-equity ratio of 0.45. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 7.640 CAD is 33.8% above the current price. The next earnings report is expected on 10 February 2027.